Dashboard Tools Market News Investing Ideas Pricing About Us
Sign Up
Log in

Affluent Medical SAS
PAR:AFME

Watchlist Manager
Affluent Medical SAS Logo
Affluent Medical SAS
PAR:AFME
Watchlist
Price: 2.81 EUR 0.36% Market Closed
Market Cap: €110.6m
Write Note Create Alert Ask AI

Affluent Medical SAS
Investor Relations

Affluent Medical SA provides treatments for serious and widespread diseases. The company is headquartered in Aix-En-Provence, Paca and currently employs 49 full-time employees. The company went IPO on 2021-06-14. The company designs minimally invasive prostheses at mimicking human anatomy and restoring native physiology for critical functions in cardiovascular and urological therapies. The company provides several products such as Kalios, Epygon, Artus. The company helps in treating heart disease and urinary incontinence. The firm provides transcatheter and flow control technologies, such as mimicry of anatomy and restoration of physiology minimally invasive implant procedures, optimized and biocompatible components.

Show more
Loading
AFME
DAX Index
1Y 3Y 5Y 10Y 15Y 20Y
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
No Earnings Calls Available

Management

Sebastien Ladet Ph.D.
Chief Executive Officer
No Bio Available
Christophe de Vregille
Chief Financial Officer
No Bio Available
Ms. Celine Buard
Marketing Director
No Bio Available
Melanie Cantal
Human Resources Manager
No Bio Available
Prof. Francois Laborde M.D., Ph.D.
Chief Surgical Officer
No Bio Available
Mr. Olivier Pierron
Deputy Chief Executive Officer
No Bio Available
Mr. Benjamin Renault Ph.D.
Chief Development Officer
No Bio Available
Dr. Christophe Giot M.D.
Chief Medical Officer & VP of Clinical Affairs
No Bio Available

Contacts

Address
PACA
Aix-en-Provence
320 avenue Archimede, Les pleiades III Batiment B
Contacts
+33442951220
www.affluentmedical.com
sparklesyt

See Also

Summary
AFME intrinsic value, competitors valuation, and company profile.
DCF Valuation
AFME stock valuation using Discount Cash Flow valuation method.
Relative Valuation
AFME stock valuation using valuation multiples.
Wall Street Estimates
AFME price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
AFME stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Back to Top
ALPHA SPREAD
Follow us
Join more than 317,100+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.